President Donald Trump announced the nomination of Dr. Erica Schwartz as director of the Centers for Disease Control and Prevention on April 16, 2026, tapping the retired U.S. Coast Guard Rear Admiral to steer the agency through persistent leadership instability.
Schwartz, who holds an MD, JD, and MPH, served as deputy surgeon general from 2019 to 2021 during Trump's first term. A Brown University graduate, she spent much of her career as a physician in the U.S. military before retiring as a rear admiral.
The Atlanta-based CDC has operated without a permanent leader since August 2025, marking over eight months of acting directors, staff firings, and reports of low morale. If confirmed by the Senate, Schwartz would replace current acting director Dr. Jay Bhattacharya.
Trump praised her qualifications in a statement released by the White House.
Admiral Brett Giroir, who preceded Schwartz as deputy surgeon general, endorsed her sharply.
Rear Admiral Schwartz is really an outstanding person in all regards. Her academic training and intellect is second to none... She's a person of the highest integrity and commitment to service to this country.Admiral Brett Giroir, former Deputy Surgeon General, told reporters after the announcement.
Public health observers noted Schwartz's support for vaccines and traditional credentials as a contrast to recent CDC turbulence. Dr. Paul Offit, a vaccine expert at Children's Hospital of Philadelphia, called the pick "a return to competence."
White House officials emphasized stability in their search. A senior aide, speaking anonymously to CNN, said the administration wanted someone who’s not crazy to calm the agency after 12 months of upheaval, including high-profile dismissals and internal clashes.
Reactions in the public health community showed cautious optimism. Dr. Ashish Jha, dean of the Brown University School of Public Health, where Schwartz studied, described her as "deeply committed to evidence-based public health." Yet some voiced concerns over potential influence from Robert F. Kennedy Jr., Trump's health secretary, known for vaccine skepticism.
STAT News reported mixed sentiments among CDC staffers. One mid-level epidemiologist, granted anonymity due to agency policies, said, "She's qualified on paper, but we've heard promises of stability before."
Senate confirmation remains uncertain. Sen. Bill Cassidy (R-La.), ranking member of the Senate Health Committee, welcomed the nomination but stressed rigorous vetting. "Public health leadership demands trust and expertise," Sen. Bill Cassidy (R-La.), ranking member of the Senate Health Committee, said in a statement.
Democrats expressed skepticism. Sen. Elizabeth Warren (D-Mass.) tweeted that the pick must prove independence from "anti-science influences in the administration."
Schwartz's military background includes deployments supporting public health missions for the Coast Guard. Her tenure as deputy surgeon general focused on military health readiness and pandemic preparedness efforts early in the COVID-19 crisis.
The CDC, with over 10,000 employees, faces ongoing challenges including infectious disease surveillance, chronic disease prevention, and rebuilding public trust post-pandemic. Schwartz's nomination arrives as the agency grapples with budget pressures and staffing shortages.
Dr. Tom Frieden, former CDC director under President Obama, urged swift action. "The CDC needs steady leadership now more than ever," Dr. Tom Frieden, former CDC director, said during an NPR interview. He highlighted Schwartz's legal training as useful for navigating regulatory hurdles.
If confirmed, Schwartz would take the helm at a time of emerging health threats, including seasonal flu surges and monitoring of novel pathogens. Her first priorities remain unclear, though Trump allies suggest a focus on "common-sense" health policies.
The Senate Health, Education, Labor, and Pensions Committee schedules hearings in the coming weeks, setting the stage for debates over her vision for the agency.
